1. Home
  2. IDXX

as of 12-18-2025 3:38pm EST

$697.66
+$2.06
+0.30%
Stocks Health Care Biotechnology: In Vitro & In Vivo Diagnostic Substances Nasdaq

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.

Chart Type:
Time Range:
Founded: 1983 Country:
United States
United States
Employees: N/A City: WESTBROOK
Market Cap: 56.2B IPO Year: 1991
Target Price: $700.50 AVG Volume (30 days): 587.0K
Analyst Decision: Buy Number of Analysts: 10
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: 12.60 EPS Growth: 21.65
52 Week Low/High: $356.14 - $769.98 Next Earning Date: 02-02-2026
Revenue: $4,167,411,000 Revenue Growth: 8.39%
Revenue Growth (this year): 12.15% Revenue Growth (next year): 8.79%

AI-Powered IDXX Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 2 days ago

AI Recommendation

hold
Model Accuracy: 75.00%
75.00%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Stock Insider Trading Activity of IDEXX Laboratories Inc. (IDXX)

Hunt Nimrata

Executive Vice President

Sell
IDXX Nov 7, 2025

Avg Cost/Share

$704.09

Shares

9,425

Total Value

$6,629,013.53

Owned After

25,459.944

SEC Form 4

Latest IDEXX Laboratories Inc. News

IDXX Breaking Stock News: Dive into IDXX Ticker-Specific Updates for Smart Investing

All IDXX News

Share on Social Networks: